Behind the EpiPen pricing scandal: Why generics don’t necessarily reduce prices – Mish proposals

Behind the EpiPen pricing scandal: Why generics don’t necessarily reduce prices – Mish proposals

By Mike “Mish” Shedlock Despite widespread availability of generic versions, customers do not often use them. Why? In some cases, pharmacies are under obligation to not mention cheaper alternatives. Some pharmacists may not be aware of cheaper alternatives because they do not know what a plan covers. And behind the scenes, there is the complex […]